Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/59059
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTuan Anh Nguyenen_US
dc.contributor.authorThang Phamen_US
dc.contributor.authorHuyen Thi Thanh Vuen_US
dc.contributor.authorThanh Xuan Nguyenen_US
dc.contributor.authorTrinh Thi Vuen_US
dc.contributor.authorBinh Thi Thanh Nguyenen_US
dc.contributor.authorNgoc Quynh Nguyenen_US
dc.contributor.authorBinh Thanh Nguyenen_US
dc.contributor.authorBinh Thanh Nguyenen_US
dc.contributor.authorTam Ngoc Nguyenen_US
dc.contributor.authorSinh Viet Phanen_US
dc.contributor.authorAnh Trung Nguyenen_US
dc.contributor.authorTuan Le Phamen_US
dc.contributor.authorHa Thu Dangen_US
dc.contributor.authorLisa Kalisch-Elletten_US
dc.contributor.authorMarianne Gillamen_US
dc.contributor.authorNicole Pratten_US
dc.contributor.authorSun Qiangen_US
dc.contributor.authorHaipeng Wangen_US
dc.contributor.authorTipaporn Kanjanarachen_US
dc.contributor.authorMohamed Azmi Ahmad Hassalien_US
dc.contributor.authorZaheer Ud Din Babaren_US
dc.contributor.authorAsrenee Ab Razaken_US
dc.contributor.authorDujrudee Chinwongen_US
dc.contributor.authorElizabeth E. Rougheaden_US
dc.date.accessioned2018-09-05T04:37:12Z-
dc.date.available2018-09-05T04:37:12Z-
dc.date.issued2018-01-01en_US
dc.identifier.issn19382731en_US
dc.identifier.issn15333175en_US
dc.identifier.other2-s2.0-85045271531en_US
dc.identifier.other10.1177/1533317518768999en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045271531&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/59059-
dc.description.abstract© 2018, The Author(s) 2018. This study examined the use of potentially inappropriate medicines that may affect cognition (PIMcog) in people with dementia and its associated factors. Medical records of all outpatients with dementia attending a tertiary hospital in Vietnam between January 1, 2015, and December 31, 2016, were examined. Medicine use was assessed against a list of PIMcog. Variables associated with having a PIMcog were assessed using a multiple logistic regression. Of the 128 patients, 41% used a PIMcog, 39.1% used cholinesterase inhibitors (CEIs) concomitantly with anticholinergics, and 18% used antipsychotics. The number of hospital visits (adjusted odds ratio [OR]: 1.08; 95% confidence interval [CI]: 1.02-1.16) and number of treating specialists (adjusted OR: 0.61; 95% CI: 0.45-0.83) were associated with PIMcog use. This study highlights a high-level use of medicines that can further impair cognition or reduce the effectiveness of CEIs in people with dementia. Efforts to improve quality use of medicines for this population are warranted.en_US
dc.subjectMedicineen_US
dc.subjectNeuroscienceen_US
dc.subjectPsychologyen_US
dc.titleUse of Potentially Inappropriate Medications in People With Dementia in Vietnam and Its Associated Factorsen_US
dc.typeJournalen_US
article.title.sourcetitleAmerican Journal of Alzheimer's Disease and other Dementiasen_US
article.stream.affiliationsUniversity of South Australiaen_US
article.stream.affiliationsNational Geriatric Hospitalen_US
article.stream.affiliationsHanoi Medical Universityen_US
article.stream.affiliationsShandong Universityen_US
article.stream.affiliationsKhon Kaen Universityen_US
article.stream.affiliationsUniversiti Sains Malaysiaen_US
article.stream.affiliationsUniversity of Huddersfielden_US
article.stream.affiliationsSchool of Medical Sciences - Universiti Sains Malaysiaen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.